For the Quarter Ending December 2022
North America
In Q4 2022, the Dimethylacetamide market in North America was observed to be bearish amid weak trading activities and weak market fundamentals. Low purchasing esteem and deteriorating demand resulted in declination in the price trend. The downstream solvent market was also affected by low purchases and feeble demand from the consumer's end. Suppliers have sufficient stocks among the enterprises to fulfill the demand from the end-user enterprises. Trade volume among the storage units surged, and high product inventories forced the producers to offer the cargo at discounts. The demand for Dimethylacetamide from the downstream solvent and adhesive industries ended up on a bearish note with cautiously operating ventures.
Asia Pacific
This quarter, the trading fundamentals of Dimethylacetamide in China slumped compared with the previous one. However, the price increased in Oct with low product inventories. The constricted supply of products coupled with the increment in trading activities affected the region's operating rate of Dimethylacetamide, leading the prices to inflate in the market. However, in Nov, falling demand for Dimethylacetamide from the downstream enterprises and weak trading fundamentals helped the prices to drop. The Dimethylacetamide market was sluggish due to the low market sentiment and limited trading to oversupplies suppliers. In China, the price of Dimethylacetamide in China slipped to USD 1303/ton FOB in Nanjing.
Europe
In Q4 2022, with declining trading fundamentals due to weak domestic demand, the significant producer offered discounts on bulk purchases. With cautiously operating manufacturing units, demand for Dimethylacetamide in the downstream solvent industry stays feeble. There was weak price support with low buying activities in the region. Ease in energy values and low production rate among the undertakings bring about oversupplies constraining the makers from clearing their current inventories. Trading of Dimethylacetamide in the European region was weak, and declining freight charges made the import prices bearish. Towards the end of the quarter, the price quotations for the end user industries declined, and the suppliers remained skeptical about declining the price further due to declining profit margin and revenue.
For the Quarter Ending September 2022
North America
In Q3 2022, the market of Dimethylacetamide declined in the USA, prompted by weak market fundamentals and sufficient product availability. In terms of the feedstock market, Dimethyl Amine prices also faced South along with production cuts among the manufacturers as a result of capacity additions in the United States. The market was also affected by the expansion of supply. Conversely, the weak North American demand impacted European trade, with the oversupply of chemicals in European business sectors. The interest from the downstream Solvent industries has been frail. The contract prices of Dimethylacetamide for the American market also declined due to weak purchasing and oversupplies of products.
Asia Pacific
This quarter, the price of Dimethylacetamide declined in the succeeding months due to adequate supply and low demand from the downstream industries. In China, the cost of Dimethylacetamide during September fell to USD 1520/ton FOB Nanjing. Due to the weak market sentiment and massive stockpiling of inventories, the market price for Dimethylacetamide crashed in the China market as the sellers accepted a lower cost to clear out stocks to start production for the next supply. The demand for Dimethylacetamide from the downstream solvent industry remained bearish, with low demand for the consumer's end. Exports from China to other Asian regions decreased due to abundant supply.
Europe
In Q3 2022, the market of Dimethylacetamide stabilized on the upper side due to rising utility and energy values in the region. The inadequate stock of Dimethylacetamide and its feedstock Dimethyl Amine in the European market made it difficult to meet the necessities in their domestic market. Regional demand for products remains tepid, which elevated the prices. However, the need for Dimethylacetamide from overseas declined due to oversupplies of products and weak market dynamics. In the domestic market, the demand slowed toward the end of the quarter due to sufficient stock and lower purchasing activities.
For the Quarter Ending June 2022
North America
In Q2 2022, the price of Dimethylacetamide surged with the increasing cost of feedstock Acetic Acid and Dimethyl amine in the US. Prices surged with bullish crude and Natural Gas prices. Accelerating demand for downstream solvent and adhesive and the stoppage of all businesses between Russia and the USA following the ongoing conflict have caused the prices to become firmer. The price trend has risen steadily with healthy demand and limited product supply. Although US chemical production gradually resumed, accessible amounts for export to Europe remained limited. Turnaround of manufacturing units of feedstock Acetic Acid in this quarter had cut the production rate resulting in a price hike.
Asia Pacific region
In Q2 2022, the price of Dimethylaceatamide slipped in April 2022 due to weak demand from downstream ventures and fluctuations in feedstock prices. However, in May and June, the prices surged with a steep inclination of purchasing and strong market sentiments. Product's Dimethylacetamide exports have been under a heavy strain from sluggish resin demand during the last few months. In April, record-high inflation coupled with tight liquidity and disappointing seasonal factors kept prices on a bearish note. Exports of Dimethylacetamide from India and China to other Asian regions surged in the second half of the quarter, maintaining a gap between supply and demand, resulting in such a price hike.
Europe
The demand for Dimethylacetamide was driven by an expansion in solvent and adhesive demand in the domestic market of Europe. The industry was combined, with a couple of huge players controlling an enormous piece of the overall market; subsequently, product makers' essential procedure was to fulfill the requirement from the consumer's end. All through the second quarter of 2022, the European market for feedstock Acetic Acid stayed positive. This change in market sentiments was connected with Europe's drawn-out energy crisis, which brought about lower production rates at manufacturing units. The downstream solvent and adhesive industries didn't catch up with the end users' requirements, forcing them to increase the prices of their products. Because of the expanded interest from the downstream business, Dimethylacetamide costs stayed tepid during the second quarter of 2022.
For the Quarter Ending March 2022
North America
In Q1 2022, the cost of Dimethylacetamide slipped all through the quarter in USA as a result of weak Acetic acid market and deterred market sentiments. Further deteriorating demand is set to continue as operating rates for significant derivative portions including adhesive and dyes endeavours were apparently high in the U.S and gave fragile perceivability on prices with the succeeding month of the quarter. We've additionally seen first the tepid visibility in the medium-term pricing environment kept on expecting adequate feedstock methanol inventories with feeble market essentials decreasing the costs. Exports to European Nations were also affected as the oversupplies of product in the overseas affected the expenses. In this quarter, the cost of Dimethylacetamide in January observed to be USD 3670/ton CFR Texas.
Asia Pacific
In Q1 2022, the cost of Dimethylacetamide remained stable with tepid market sentiments in the domestic market of India. In February 2022, The Bureau of Indian Standards (BIS) had bound to compel new quality control rules for Methanol imports which make issues for the vendors to meet the specifications. Underlying market opinions for Naphtha stays weak on determined worry over offset olefin and aromatic margins. Usage of Dimethylacetamide in adhesive ventures was moreover extended with accelerating demand from the end users. In India, the expense of Dimethylacetamide towards the quarter end was assessed to be USD 2555/ton Ex-Mumbai. In China, the market remained feeble, and the Commodity Exchange prospects similarly decreased as the interest from downstream endeavours was not consistent.
Europe
European Dimethylacetamide market remained on the lower side with declining demand in Q1 2022 when compared with previous quarter. Demand remained frail and the stockpile was adequate which brought such expense design. Major downstream derivative producer organizations had kept up with costs on their product regardless of slow interest and accumulation of inventories. Feedstock Acetic Acid showed level of frail trading environment and producers had moved from negotiation mechanism and rather decreased the expenses on account of sufficient accessibility and lower production cost. Downstream adhesive industries had in like manner slipped, and the demand/supply harmony became unstable. In Germany, the price of Dimethylacetamide during January were observed to be USD 4025/ton FD Hamburg.
For the Quarter Ending December 2021
North America
High raw material cost amid stable offtakes from the domestic downstream sectors, pushed up the prices of several commodities including Dimethylacetamide (DMAC) across the region. Pharma sector of USA showcased overall stability during this timeframe, while major pharma intermediates and raw material climbed up on the back of inflationary pressure induced due to high upstream values and high domestic consumption. In addition, export demand also remained buoyant from European market, as rebound in regional consumption and soaring input cost compelled European traders to look forward for cheaper imports from other regions. Conclusively, DMAC price remained buoyant throughout the quarter while showcasing marginal fluctuations of around USD 80-120/MT during Q4 2021.
Asia
On the back of soaring upstream cost, drastic change in Dimethylacetamide (DMAC) prices has been observed throughout the quarter. Several downstream consumers from paints and pharma sector were very cautious about this steep inclination in price trend of the product. Furthermore, after government decision on removing charges from keeping shipping container for more than waiting time at port down, exporters were able to export more cargoes than before, and thus export activities improved respectively from India. DMAC price revolved around USD 2180/MT during December in India. Meanwhile, Chinese market remained cautious about rising cost of several commodities including DMAC in the country. On the other hand, production contains across the country, due to soaring energy cost and dual energy policy related restrictions.
Europe
Rising raw material cost caused concerns for major European players as the domestic demand for the pharma products remained modest to form while consumption as well as well regional trade activities were high in the meantime. In addition, UK market heard facing difficulties in domestic transport due to shortage of labour force. Furthermore, exorbitant surge in natural gas value also remained a matter of concern for regional players, as upstream values surging in uncontrolled manner. Thus, between this market turmoil, DMAC price maintained overall firmness throughout Q4 2021 in Europe.
The prices of Dimethylacetamide rose effectively in the North American region during Q3 2021 owing to strong demand from the downstream agrochemicals, pharmaceuticals, and synthetic fibers (Polyacrylonitrile and polyurethane) markets. In terms of supply, it has remained tight throughout Q3 due to a continuous rise in the prices of upstream feedstock Acetic Acid. Limited availability of raw materials and increased shipping charges and high freight costs are some of the factors that resulted in the upward momentum of dimethylacetamide prices across the region in this quarter.
The domestic Asian Market witnessed an upward trajectory in the third quarter of 2021. In India, the prices of dimethylacetamide have been on a constant rise throughout the quarter due to the strong demand from the agrochemicals, pharmaceuticals, and textile industries. The supply has been disrupted in Q3 due to consistently increased prices of upstream acetic acid in the region. Dimethylacetamide FOB Mumbai (India) prices shot up from USD 1899/MT to USD 2037/MT from July to September. High freight charges and constrained material availability have further caused an increment in the pricing trend of dimethylacetamide in Q3 2021.
The market trend of Dimethylacetamide witnessed an upward trajectory across the European region in Q3 of 2021. In terms of demand, offtakes from the downstream pharmaceutical and agrochemical sector improved during this quarter. Taking support from soaring feedstock prices and tight availability of raw materials amidst stable to firm demand, prices of Dimethylacetamide significantly increased in Europe in Q3.
